ReviewCancer management and research2019

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

Marie Alexandre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.